These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11462220)

  • 1. Gene therapy and retinitis pigmentosa: advances and future challenges.
    Dejneka NS; Bennett J
    Bioessays; 2001 Jul; 23(7):662-8. PubMed ID: 11462220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Sakamoto T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Ishibashi T; Sueishi K
    Gene Ther; 2003 Aug; 10(17):1503-11. PubMed ID: 12900766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
    Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
    Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for retinitis pigmentosa.
    Bennett J
    Curr Opin Mol Ther; 2000 Aug; 2(4):420-5. PubMed ID: 11249772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of inherited dystrophies and neovascular disorders of the retina by rAAV-mediated gene therapy].
    Stieger K; Lorenz B
    Klin Monbl Augenheilkd; 2008 Dec; 225(12):1009-23. PubMed ID: 19085778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?
    Veltel S; Wittinghofer A
    Expert Opin Ther Targets; 2009 Oct; 13(10):1239-51. PubMed ID: 19702441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in treatment of retinitis pigmentosa by neurotrophic factors].
    Zhang X; Li GL
    Zhonghua Yan Ke Za Zhi; 2009 Sep; 45(9):855-9. PubMed ID: 20137292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for retinal gene replacement therapy.
    Smith AJ; Bainbridge JW; Ali RR
    Trends Genet; 2009 Apr; 25(4):156-65. PubMed ID: 19303164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes.
    Phelan JK; Bok D
    Mol Vis; 2000 Jul; 6():116-24. PubMed ID: 10889272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategies in RP (retinitis pigmentosa): light at the end of the tunnel?].
    Abegg M; Hafezi F; Wenzel A; Grimm C; Remé CE
    Klin Monbl Augenheilkd; 2000 Feb; 216(2):83-9. PubMed ID: 10730223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa.
    Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Kohno R; Murakami Y; Inoue M; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
    J Gene Med; 2008 Dec; 10(12):1273-81. PubMed ID: 18837062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early therapeutic trials for retinitis pigmentosa].
    Dufier JL
    Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leber congenital amaurosis: genes, proteins and disease mechanisms.
    den Hollander AI; Roepman R; Koenekoop RK; Cremers FP
    Prog Retin Eye Res; 2008 Jul; 27(4):391-419. PubMed ID: 18632300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment possibilities for retinitis pigmentosa.
    Jacobson SG; Cideciyan AV
    N Engl J Med; 2010 Oct; 363(17):1669-71. PubMed ID: 20961252
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary degenerative retinopathies: optimism for somatic gene therapy.
    Shastry BS
    IUBMB Life; 2000 Jun; 49(6):479-84. PubMed ID: 11032240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).
    Tam LC; Kiang AS; Kennan A; Kenna PF; Chadderton N; Ader M; Palfi A; Aherne A; Ayuso C; Campbell M; Reynolds A; McKee A; Humphries MM; Farrar GJ; Humphries P
    Hum Mol Genet; 2008 Jul; 17(14):2084-100. PubMed ID: 18385099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in molecular genetics and gene therapy for retinitis pigmentosa].
    Wang DY; Fan BJ; Wu XQ; Chan WM; Lam SC; Pang CP
    Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):188-92. PubMed ID: 15840355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental therapeutic modalities for retinitis pigmentosa].
    Chowers I; Banin E
    Harefuah; 2003 Apr; 142(4):277-80, 317. PubMed ID: 12754878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retinal pigmentary degeneration--clinical features, diagnostics and possibilities of treatment].
    Grześk M; Malukiewicz-Wiśniewska G
    Klin Oczna; 2007; 109(4-6):230-4. PubMed ID: 17725295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.